Diabetic Macular Edema

Showing NaN - NaN of 35

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in San Antonio (D-4517.2)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema
  • Los Angeles, California
  • +11 more
Jan 11, 2023

Diabetic Macular Edema Trial in Puerto Rico, United States (CU06-1004)

Recruiting
  • Diabetic Macular Edema
  • Baltimore, Maryland
  • +9 more
Dec 13, 2022

Diabetic Macular Edema Trial in United States (intravitreous aflibercept, Bevacizumab + Deferred Aflibercept Group)

Completed
  • Diabetic Macular Edema
  • intravitreous aflibercept
  • Bevacizumab + Deferred Aflibercept Group
  • Campbell, California
  • +53 more
Nov 28, 2022

Diabetic Macular Edema Trial in Latvia, United States (KSI-301, Aflibercept, Sham Procedure)

Active, not recruiting
  • Diabetic Macular Edema
  • Bakersfield, California
  • +45 more
Jun 2, 2022

Diabetic Macular Edema Trial in Worldwide (Aflibercept, Faricimab, Sham Procedure)

Completed
  • Diabetic Macular Edema
  • Phoenix, Arizona
  • +194 more
Apr 1, 2022

Diabetic Macular Edema Trial in Worldwide (Aflibercept, Faricimab, Sham Procedure)

Completed
  • Diabetic Macular Edema
  • Mesa, Arizona
  • +184 more
Apr 1, 2022

Diabetic Macular Edema, Retina Vein Occlusion Trial in United States (GB-102)

Completed
  • Diabetic Macular Edema
  • Retina Vein Occlusion
  • Phoenix, Arizona
  • +5 more
Nov 18, 2021

Diabetic Macular Edema Trial in United States (KVD001 Injection, Sham Procedure)

Completed
  • Diabetic Macular Edema
  • KVD001 Injection
  • Sham Procedure
  • Phoenix, Arizona
  • +34 more
Jan 5, 2021

Retinal Vein Occlusion, Diabetic Macular Edema Trial in Beverly Hills, Boston (KPI-121 0.25% Ophthalmic Suspension, KPI-121 1.0%

Completed
  • Retinal Vein Occlusion
  • Diabetic Macular Edema
  • KPI-121 0.25% Ophthalmic Suspension
  • KPI-121 1.0% Ophthalmic Suspension
  • Beverly Hills, California
  • +1 more
Dec 9, 2020

Diabetic Retinopathy, Diabetic Macular Edema Trial in Canada, United States (Pemafibrate, Placebo)

Terminated
  • Diabetic Retinopathy
  • Diabetic Macular Edema
  • Phoenix, Arizona
  • +70 more
Aug 27, 2020

Diabetic Macular Edema Trial in United States (2.0 mg intravitreal aflibercept, 1.25 mg intravitreal bevacizumab, 0.3 mg

Completed
  • Diabetic Macular Edema
  • 2.0 mg intravitreal aflibercept
  • +2 more
  • Tucson, Arizona
  • +89 more
Jul 22, 2020

Evaluation of Vitrectomy for Diabetic Macular Edema

Completed
  • Diabetic Retinopathy
  • Diabetic Macular Edema
    • Irvine, California
    • +47 more
    Sep 20, 2019

    Diabetes, Diabetic Retinopathy, Diabetic Macular Edema Trial in United States (THR-149 dose level 1, THR-149 dose level 2,

    Completed
    • Diabetes Mellitus
    • +2 more
    • THR-149 dose level 1
    • +2 more
    • Phoenix, Arizona
    • +6 more
    Jun 12, 2019

    Diabetes, Diabetic Macular Edema Trial in United States (ASP8232, ranibizumab, Placebo)

    Completed
    • Diabetes Mellitus
    • Diabetic Macular Edema
    • Phoenix, Arizona
    • +20 more
    Mar 4, 2019

    Diabetic Macular Edema Trial in United States (REGN910-3, Intravitreal Aflibercept Injection (IAI))

    Completed
    • Diabetic Macular Edema
    • REGN910-3
    • Intravitreal Aflibercept Injection (IAI)
    • Mesa, Arizona
    • +50 more
    Oct 1, 2018

    Diabetic Macular Edema Trial in United States (intravitreal ranibizumab 0.3 mg, dexamethasone intravitreal implant, Sham

    Completed
    • Diabetic Macular Edema
    • intravitreal ranibizumab 0.3 mg
    • +2 more
    • Beverly Hills, California
    • +55 more
    Sep 24, 2018

    Diabetic Macular Edema Trial in United States (nepafenac 0.1% drops, Nepafenac Vehicle)

    Completed
    • Diabetic Macular Edema
    • nepafenac 0.1% drops
    • Nepafenac Vehicle
    • Loma Linda, California
    • +31 more
    Aug 21, 2018

    Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema Trial in United States (DS-7080a, Ranibizumab)

    Completed
    • Neovascular Age-Related Macular Degeneration
    • Diabetic Macular Edema
    • Phoenix, Arizona
    • +11 more
    May 8, 2018

    Diabetes, Diabetic Macular Edema, Diabetic Retinopathy Trial in United States (OCT imaging)

    Completed
    • Diabetes
    • +2 more
    • OCT imaging
    • Boston, Massachusetts
    • +3 more
    Nov 22, 2017

    Diabetic Macular Edema Trial in United States (Ranibizumab, Laser photocoagulation)

    Completed
    • Diabetic Macular Edema
    • Phoenix, Arizona
    • +19 more
    Mar 20, 2017

    Diabetic Macular Edema Trial in United States (KVD001 Injection)

    Completed
    • Diabetic Macular Edema
    • KVD001 Injection
    • Beverly Hills, California
    • +4 more
    Mar 1, 2017

    Diabetic Macular Edema Trial in Worldwide (Ruboxistaurin, Placebo)

    Completed
    • Diabetic Macular Edema
    • Phoenix, Arizona
    • +40 more
    Aug 25, 2016

    Diabetic Macular Edema Trial in United States (Efalizumab, Ranibizumab)

    Withdrawn
    • Diabetic Macular Edema
    • Tucson, Arizona
    • +9 more
    Aug 25, 2016

    The Course of Response to Focal Photocoagulation for DME

    Completed
    • Diabetic Retinopathy
    • Diabetic Macular Edema
    • Laser photocoagulation
    • Palm Springs, California
    • +31 more
    Aug 25, 2016

    Proliferative Diabetic Retinopathy, Diabetic Macular Edema Trial in United States (drug, behavioral, procedure)

    Completed
    • Proliferative Diabetic Retinopathy
    • Diabetic Macular Edema
    • Artesia, California
    • +55 more
    Aug 25, 2016